In the event the reconciliation Monthly bill at the moment being debated in Congress contains Medicare-only drug price tag limitations, the 180 million Us residents with non-public health coverage could well be still left at the rear of.The Draw back: Pharma giants warn that cutting profits could undermine R&D, slowing the development of new drug